Rheumatology Search
Rheumatology Rheumatology
gout
GOUT
Gout is a condition that resulted from deposition of monosodium urate crystals in various tissues (eg joints, connective tissue, kidney).
The patient experiences acute and chronic arthritis, soft tissue inflammation, tophus formation, gouty nephropathy and nephrolithiasis.
Primary hyperuricemia is called when uric acid saturation arises without coexisting diseases or drugs that alter uric acid production and excretion.
While in secondary hyperuricemia there is an excessive uric acid production or diminished renal clearance that occurs as a result of a disease, drug, dietary product or toxin.

Definition

  • Gout is a condition wherein there is increased uric acid or urate in the body, also called hyperuricemia, that leads to deposition of monosodium urate monohydrate crystals in various tissues (eg joints, connective tissue, kidney)

Pathophysiology

  • Hyperuricemia is a necessary precondition for the development of monosodium urate monohydrate crystal deposition but this has to be distinguished from gout, the clinical syndrome
  • Results in acute & chronic inflammation associated with changes in articular & periarticular structures

Epidemiology

  • Affects up to 1-2% of adults & is the most common inflammatory arthritis in men
  • Prevalence of gout in the Asia-Pacific region varies
    • Ethnic groups in China & Malaysia (eg Malays, Tamils) were found to have higher uric levels as compared to the Japanese & Thai
    • Taiwan is one of the countries in the world with highest prevalence of gout

Risk Factors

Risk factors for gout & associated comorbidity should be assessed

Risk factors associated with gout:

  • Hyperuricemia
    • Single most important risk factor for developing gout
  • Male sex
  • Menopausal women
  • Age
  • Purine-rich diet (eg meat, seafood)
  • Alcohol intake
  • Diuretic use
  • Other drug use (eg low-dose Aspirin, antihypertensive medications, Ciclosporin)
  • Lead exposure

Metabolic abnormalities associated with gout:

  • Hypertension
  • Obesity
  • Dyslipidemia
  • Hyperglycemia & insulin resistance

Comorbidities associated with gout:

  • Coronary artery disease
  • Type 2 diabetes mellitus
  • Renal insufficiency
  • Metabolic syndrome
  • Kidney stone
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Beta-blockers may reduce mortality in patients with heart failure, renal dysfunction
Roshini Claire Anthony, 6 days ago

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
Early-life exposures affect BP in children
6 days ago
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Short sleepers at higher risk of myocardial infarction
6 days ago
Short sleep duration is associated with an increased risk of myocardial infarction (MI), according to prospective observational and Mendelian randomization (MR) analyses.
Ezetimibe boosts statin effect in ACS patients with dyslipidaemia, low EPA/AA ratio
Tristan Manalac, 6 days ago
The addition of ezetimibe improves statin treatment in acute coronary syndrome (ACS) patients with dyslipidaemia and low eicosapentaenoic acid-to-arachidonic acid (EPA/AA) ratio, resulting in a lowered risk of cardiovascular events compared to monotherapy, according to a study presented at the recently concluded 2019 Congress of the European Society of Cardiology (ESC 2019) held in Paris, France.